PODLESAK DENNIS purchased 47.6% of their position (13.97K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market purchase worth $197.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/22/2021ACC: 0001562180-21-002912
Director
Since Jun 2019
+13.97K
Net shares
Net buyer
$197.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
13.97K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+13.97K
Price / share
$14.11
Trade value
$197.08K
% of position
47.6%
4/22/2021
29.33K→43.30K
Total
Net shares
+13.97K
Net value
$197.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/22/2021 | P · Purchase | +13.97K | $14.11 | $197.08K | 47.6% | 29.33K | 43.30K |
| Total | +13.97K | $197.08K | ||||||
Derivative Transactions0
No derivative transactions reported